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Background: Metalloprotease FtsH is involved in 
quality control of membrane proteins 
Results: Simultaneous (or sequential) expression 
of misfolded DrrAB and FtsH results in significant 
recovery of DrrAB-mediated doxorubicin efflux 
function.   
Conclusion: FtsH facilitates refolding of 
previously misassembled DrrAB. 
Significance: This is the first study showing that 
FtsH contains both protease and refolding 
functions and plays a dual role in biogenesis of 
membrane proteins.  
 
SUMMARY 
This study provides the first direct 
evidence for the dual role of the 
metalloprotease FtsH in membrane protein 
biogenesis.  Using the physiological substrate 
DrrAB, it is shown that FtsH is not only 
responsible for proteolysis of unassembled 
DrrB protein but it also plays a much broader 
role in biogenesis of the DrrAB complex.  
Previous studies showed that the stable 
expression of DrrB in the membrane depends 
on simultaneous expression of DrrA.  Here we 
show that DrrB is proteolyzed by FtsH when it 
is expressed alone.  Moreover, DrrA and DrrB 
proteins expressed together in a temp-sensitive 
ftsH mutant strain of E. coli were found to be 
non-functional due to their incorrect assembly.  
Simultaneous expression of wild-type FtsH in 
trans resulted in normal doxorubicin efflux.  
Strikingly, doxorubicin efflux could be restored 
in mutant cells irrespective of whether FtsH 
was expressed simultaneously with DrrAB or 
expressed after these proteins had already 
accumulated in an inactive conformation, thus 
providing crucial evidence for the ability of 
FtsH to refold the misassembled proteins.  
Complementation experiments also showed that 
the catalytic AAA domain of FtsH contains a 
chaperone-like activity, however, unlike wild-
type FtsH, it was unable to restore function.  
Our results therefore show for the first time 
that FtsH contains the protease as well as 
refolding functions, and both the AAA and the 
proteolytic domains of FtsH are required for 
each of these activities. 
Membrane proteins play essential roles in 
cell physiology.  They carry out import of 
nutrients, export of toxins, antibiotics and drugs, 
and play important roles in energy and signal 
transduction.   Improper assembly of membrane 
proteins is known to result in various diseases.  
However, because of the complexity of the 
assembly process and the diverse array of factors 
involved, understanding mechanisms of membrane 
protein assembly poses a serious challenge.  The 
bacterial DrrAB (doxorubicin resistance proteins 
A and B) system is an attractive model for 
studying assembly of ABC (ATP-Binding Cassette) 
transporters.  In this system, the catalytic function 
(DrrA) and the transport function (DrrB) are 
present on separate subunits (1), which together 
form a tetrameric complex in the membrane (2) 
and carry out ATP-dependent efflux of the anti-
cancer drugs doxorubicin (Dox) and daunorubicin 
(3).  Previous studies from this lab suggested that 
for proper function of the DrrAB complex the 
DrrA and DrrB proteins may be required to co-
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assemble (4).  It was also shown that interaction 
between DrrA and DrrB is essential for stable 
maintenance of DrrB in the membrane so that the 
expression of DrrB is undetectable in the absence 
of a simultaneous expression of DrrA (2).  Co-
expression of DrrA in cis or trans restores the 
wild-type levels of DrrB expression, therefore 
suggesting that DrrA protects DrrB from 
proteolysis by a cellular protease.  The nature of 
the protease and whether it plays a specific role in 
quality control and biogenesis of the DrrAB 
complex has so far remained uncharacterized.  In 
this study, we examine the role of FtsH (filament 
temperature-sensitive protein H) in this process.   
FtsH is a zinc-dependent metalloprotease 
which belongs to the AAA (ATPases Associated 
with Diverse Cellular Activities) family of 
proteins.  Along with other proteases, such as 
ClpAP, ClpXP, HsIUV, and Lon, these proteins 
form the large AAA+ superfamily of proteins, 
members of which share a similar AAA-ATPase 
domain (5).  FtsH is evolutionarily conserved with 
more than 40% sequence identity observed 
between bacterial, yeast and human homologs (6).  
E. coli FtsH is the best studied of all known 
members, and it has been shown to be the only 
growth-essential protease in E. coli.  Yeast cells 
lacking the three FtsH orthologs (two m-AAA and 
one i-AAA) were also found to be non-viable, 
demonstrating the essential function of this 
enzyme in eukaryotic cells (6,7).  FtsH is unique 
in being embedded in the cell membrane in E. coli, 
and in the mitochondrial inner membrane in 
eukaryotes (8), where it forms homohexameric 
ring-like structures.  The major role of FtsH is 
believed to be in the quality control of specific 
membrane proteins, such as degradation of the 
unassembled SecY and subunit ‘a’ of F0 sector of 
the ATP synthase, in addition to modulating levels 
of some soluble regulatory proteins (8-10). 
FtsH contains two transmembrane helices 
at the N terminus, followed by a cytoplasmic 
domain containing the catalytic AAA domain in 
the middle and the proteolytic domain at the C 
terminus.  The AAA domain (residues 144-398) 
consists of the conserved Walker A, Walker B and 
SRH (second region of homology) motifs, which 
are essential for ATP binding and hydrolysis (8).  
The proteolytic domain contains the conserved 
Zn2+ binding motif H417EXXH421, the third Zn2+-
ligand residue E479, and the coiled-coil leucine-
zipper sequence (8).  FtsH carries out proteolysis 
of polypeptides in an ATP and Zn2+-dependent 
manner, while other AAA+ proteases, such as Lon 
and ClpA/P, are serine peptidases (11).  To initiate 
proteolysis of a membrane protein, the putative 
polypeptide binding site in the catalytic AAA 
domain of FtsH is believed to capture the 
cytoplasmic tail (either at the N or the C terminus) 
of the membrane substrate, followed by 
dislocation and processive unfolding of the protein 
to an open structure (8).  Therefore, both the 
catalytic AAA domain and the proteolytic domain 
are required for proteolysis. 
Although the major function of the AAA+ 
proteases is in proteolysis, they also exhibit 
chaperone-like activities, which allow them to 
monitor the folding status of a protein, promote 
disassembly or unfolding (12), and specifically 
degrade non-native proteins (13).  For a long time, 
it has been speculated that the AAA+ proteases 
may also have the ability to refold their substrate 
proteins (14), which remains an open question till 
date (15).  FtsH was originally identified by Ito 
and co-workers in a screen to isolate factors which 
may assist in membrane protein assembly (16).  
They used SecY-PhoA fusion to screen for stop-
transfer defect (Std) mutations, and found that 
such a mutation lies in the ftsH gene.  Depletion of 
FtsH also resulted in significant export defects of 
β-lactamase and OmpA in E. coli in addition to 
causing a strong Std phenotype.  Together, these 
studies indicated that FtsH may be involved in 
protein assembly into and through the membrane 
and may play a role in determining orientation of 
membrane proteins (16).  In another study, FtsH 
orthologs Yta10 and Yta12 in yeast mitochondria 
were shown to be required for the formation of a 
48 kDa assembly intermediate of the F0 subunit 9 
(17).  Finally, in vitro studies showed that the 
purified AAA domain of Yme1, a yeast 
mitochondrial homolog of FtsH, suppresses 
aggregation of a model polypeptide (18).  Despite 
these observations, however, no direct evidence 
for the role of FtsH or its homologs in functional 
assembly of membrane proteins has been obtained 
so far.  
In this study, we provide the first direct 
evidence that FtsH is a dual function enzyme 
containing both the protease and assembly 
functions.  We show that not only is FtsH 
responsible for removal of the unassembled DrrB 
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but that it is actually able to refold previously 
misassembled DrrAB proteins and restore Dox 
efflux function of the complex.  Our results also 
show that while the AAA domain of FtsH provides 
recognition and specificity for binding of the 
substrate, both ATP hydrolysis and the proteolytic 
functions of FtsH are used concurrently for 
refolding of DrrAB and restoration of function.  
Our studies, therefore, not only shed light on the 
mechanism of assembly of the DrrAB complex but 
also further elucidate the function of the FtsH 
protease.   
 
EXPERIMENTAL PROCEDURES 
Strains and plasmids – The E. coli strains and 
plasmids are described in Table 1.  
Media and growth conditions – E. coli cells were 
normally grown in LB medium at 30°C or 37 °C, 
unless indicated otherwise.  Chloramphenicol, 
kanamycin, or ampicillin was added to a final 
concentration of 20, 30 or 100 µg/ml, respectively, 
where indicated.  E. coli cells used for the Dox 
efflux assay were grown in TEA medium (3). 
Site-directed mutagenesis of ftsH – Site-directed 
mutagenesis of the ftsH gene was carried out by a 
Strategene QuickChange Multisite-directed 
mutagenesis kit (La Jolla, CA).  Using 
pUC18/ftsH plasmid as the template, Lys198, 
located in the conserved Walker A motif of the 
AAA domain, was changed to aspargine.  The 
resulting plasmid was named pUCftsH(K198N).  
Another mutant, named ftsH(HEH), was obtained 
by substituting His417Glu418His421 in the conserved 
HEAGH motif present in the proteolytic domain to 
Ala417Gln418Ala421.  The primers for both 
substitutions are shown in Table S1. 
Subcloning of the AAA domain of ftsH into pUC18 
vector – To completely remove the proteolytic 
domain, a fragment of ftsH corresponding to the 
first 1194 base pairs was PCR-amplified and 
ligated into the pUC18 vector using the EcoRI and 
HindIII restriction enzymes resulting in 
pUC18(AAA).  This construct is referred to as 
ftsH(AAA) in this article. The primers are shown 
in Table S1.  
Subcloning of ftsH and the groESL genes– Wild-
type ftsH, ftsH(K198N),  ftsH(HEH) and 
ftsH(AAA) genes were subcloned into pET28a 
vector using SnaBI and HindIII restriction 
enzymes.  The resulting plasmids were named 
pETftsH, pETftsH(K198N), pETftsH(HEH) and 
pETftsH(AAA), respectively.  The groES/L genes 
were subcloned from pKY326 (19) into pUC18 
vector using EcoRI and SmaI restriction enzymes 
resulting in pUCgroESL 
Cloning of ftsH into the pBAD vector– Using 
pBAD/HisA (Invitrogen) as a template, a 3.9kb 
fragment between NcoI and HindIII sites was 
amplified.  The NcoI site was substituted with the 
XhoI site in the primers used for amplification 
(Table S1).  This resulted in deletion of the 
multiple cloning sites and the polyhistidine region.  
The ftsH gene was amplifed from pUCftsH using 
primers containing XhoI and HindIII sites and 
ligated to the above fragment.  
Growth and Protein expression – E. coli TG1, 
AR796, AR797, E. coli SG1110, and E. coli 
SG1126 cells containing the indicated plasmids 
were grown at 30 °C or 37 °C to mid-log phase 
(A600nm=0.6).  The proteins were induced by 
addition of 0.1 or 0.25 mM IPTG, and the 
incubation was continued at 30 °C, 37 °C, or 
42 °C for 3 h.  The cells were spun down, 
resuspended in 5 ml lysis buffer (2 mM Tris-Cl, 
pH 7.5, 20% glycerol, 2mM EDTA, 1 mM DTT) 
and lysed by a single passage through a French 
pressure cell at 20,000 p.s.i.  After centrifugation 
at 10,000 X g for 15 min, the pellet represented the 
inclusion body fraction.  The supernatant was 
centrifuged at 100,000 X g for 1 h to separate the 
supernatant (cytosolic fraction) and the pellet 
(membrane fraction).  The membrane, cytosol and 
the inclusion body fractions were analyzed by 12% 
SDS-PAGE, followed by Western-blot analysis 
using anti-DrrA or anti-DrrB antibodies (2).   
Purification of the FtsH protein – FtsH protein 
was purified according to published protocols (9) 
with modifications.  E. coli HMS174(DE3) cells 
containing the pETftsH plasmid or its variants 
were inoculated in 1liter LB medium 
supplemented with 30 µg/ml kanamycin at 37 °C.  
The cells were grown to mid-log phase and 
induced with 0.25 mM IPTG at 20 °C overnight.  
The membrane fraction was prepared as described 
earlier (2).  5 mg of the membrane fraction was 
solubilized with 5 ml solubilization buffer (50 mM 
Tris-Cl, pH7.5, 500 mM KCl, 0.5 % (w/v) Nonidet 
P-40, 15% (w/v) Glycerol, 2.9 mM 2-
mercaptoethanol).  The solubilized protein was 
purified using Ni2+ -NTA-agarose column and 
eluted with a gradient of 50 to 500 mM imidazole.  
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Fractions containing FtsH were collected and 
dialyzed against 2 liters of the dialysis buffer (10 
mM Tris-Cl, pH7.5, 15% (w/v) glycerol, 50 mM 
KCl, 0.5% (w/v) Nonidet P-40, 5mM MgCl2, 1 
mM dithiothreitol) for 12 hours.  The protein was 
stored at -80 °C until used.   
ATPase activity assay – The ATPase activity of 
FtsH was detected by the malachite green-
ammonium molybdate colorimetric assay (9).   
In vivo FtsH Proteolytic assay - Membrane-bound 
DrrAB proteins were used as a substrate to 
determine the proteolytic activity of FtsH.  pBAD 
vector or the pBADftsH plasmid was transformed 
into AR797 cells containing pDX101 
(pSU2718drrAB).  The cells were grown in LB 
medium to mid-log phase and the DrrAB proteins 
were induced with 0.25 mM IPTG at 42 °C for 1 h.  
To terminate the synthesis of DrrAB, 1000 µg/ml 
chloramphenicol was added to the cell culture and 
incubated at 42 °C for 30 min.  The cells were 
washed extensively to remove chloramphenicol 
and IPTG.  After resuspending the cells in fresh 
medium, synthesis of FtsH from the pBADftsH 
plasmid was induced by addition of 0.2% 
arabinose at 42 °C.  An aliquot of cell culture was 
taken out at 0, 30, 60, 90, 120 and 180 min.  
Membrane fractions were prepared as described 
above, and 20 µg total membrane protein was 
loaded onto 12% SDS-PAGE, followed by 
Western-blot analysis using anti-DrrA, anti-DrrB 
or anti-FtsH antibodies.  
In vitro FtsH Proteolytic assay - α-Casein was 
used as a substrate in vitro to demonstrate the 
proteolytic activity of purified FtsH and the 
FtsH(HEH) protein (20).  40 µg of α-casein 
(Sigma Aldrich) was mixed with 40 µg purified 
FtsH or FtsH (HEH) in 150 µl protease buffer (50 
mM Tris-Cl, pH8.0, 20 mM KCl, 5 mM MgCl2, 
12.5 µM Zn(OAc)2, 0.5 % (w/v) NP-40, 10 % 
(w/v) glycerol, 1 mM dithiothreitol) at 42 °C.  The 
reaction was initiated by adding 8 mM ATP, and 
an aliquot (20 µl) of the sample was taken out at 
the indicated time points.  The reaction was 
terminated by adding 7 µl of 4×SDS sample buffer.  
The samples were analyzed by 12% SDS-PAGE, 
followed by Coomassie Brilliant blue staining.  
Whole cell Dox efflux assay – The whole cell Dox 
efflux assay was carried out according to the 
protocol published previously (3).  The 
fluorescence spectra were recorded on an 
Alphascan-2 spectrofluorometer (Photon 
Technology International, London, Ontario, 
Canada).  The slope of the Dox efflux curve of the 
positive control (the first sample) in each panel 
was designated as 1.0.  The efficiency of Dox 
efflux of each sample within one panel was 
calculated by dividing the slope of the efflux curve 
by the slope of sample 1.  The average data 
obtained from three independent experiments were 
plotted in the histograms 
 
RESULTS  
FtsH is responsible for the proteolysis of 
unassembled DrrB – Previous studies from this 
laboratory showed that DrrB is undetectable in 
wild-type E. coli membranes in the absence of 
simultaneous expression of DrrA ((2), Fig 1A, 
lane 2), however stable expression of DrrB is seen 
when both DrrA and DrrB are expressed together 
(lane 1).  These results suggest that DrrB is 
completely degraded when not complexed with 
DrrA.  Review of recent literature suggested that 
proteins of the AAA+ family, especially FtsH, may 
be involved in the quality control of membrane 
proteins (13).  To determine if this is true for DrrB, 
three proteases, including Lon, ClpA/ClpP and 
FtsH, were investigated.  If any of these proteases 
is responsible for degradation of unassembled 
DrrB, stable expression of DrrB will be observed 
in cells deficient in that protease as compared to 
the wild-type cells.  The FtsH-deficient E. coli 
AR797 strain (Table 1) used in this study contains 
a temperature sensitive mutation in the ftsH gene, 
therefore it was grown at 30 °C but the 
temperature was switched to 42 °C to inactivate 
FtsH.  The Lon- (SG1110) and the ClpA- (SG1126) 
cells were grown normally at 30 °C or 37 °C.  The 
isogenic E. coli AR796 parent strain was used as a 
control.  Of the 3 protease-deficient strains tested, 
only the FtsH-deficient E. coli cells showed stable 
expression of DrrB in the absence of DrrA (Fig. 
1B, lanes 1-3) (Fig. 1C, lane 2), while the Lon- and 
the ClpA- cells showed no effect on the stability of 
DrrB (Fig. 1C, lanes 3-4).  Since DrrB was not 
seen in AR796 (wild-type) cells at either 30 °C or 
42 °C (Fig. 1B, lanes 1 and 2), but it was stably 
expressed in the 797 (FtsHts) cells at 42 °C (lane 3), 
these results show that FtsH degrades unassembled 
DrrB.  In contrast to the expression of DrrB alone, 
when both DrrA and DrrB were expressed 
together in wild-type 796 cells at 30 °C or 42 °C, 
stable expression of DrrB was seen (Fig. 1B, lanes 
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4 and 5), confirming that DrrA protects DrrB 
against FtsH proteolysis.  Note that the amount of 
DrrA and DrrB in the wild-type  cells was less at 
42 °C as compared to at 30 °C (Fig. 1B, lanes 4-5), 
suggesting that the DrrAB complex acquires a 
more open conformation at higher temperature 
resulting in partial proteolysis by endogenous FtsH.  
Protection of DrrB from FtsH proteolysis by DrrA 
was also seen in the ClpA- and Lon- backgrounds 
(Fig. 1C, lanes 5-6).  Together, the data in Fig. 1 
show that FtsH plays an important role in quality 
control of the DrrB protein when DrrA is absent.  
To rule out the possibility that DrrA or DrrB may 
aggregate when their expression is induced at 
42 °C, the membrane, cytosol, and inclusion body 
fractions were prepared from both wild type and 
FtsHts cells and analyzed by Western blotting 
using anti-DrrA and anti-DrrB antibodies.  The 
data in Fig. 2 show that although some DrrB 
protein is present in the inclusion body fraction in 
both wild type (lower panel, lane 3) and the FtsHts 
cells (lane 9) at 30 °C, the induction of either 
strain at 42 °C did not result in any increase in the 
amount of inclusion body formation (lower panel, 
lanes 6 and 12).  Moreover, no aggregated DrrAB 
proteins were seen in the stacking region of the gel 
in any of the fractions of wild type or FtsHts cells, 
indicating absence of any significant aggregation 
under the conditions used in these experiments.  
Note that the anti-DrrB antibody is an anti-peptide 
antibody, therefore it shows some cross-reactivity 
with epitopes in some other E. coli proteins, as 
explained in a previous publication (1).  
Expression of DrrB alone or DrrAB 
together in FtsH-deficient cells results in growth 
inhibition-  The growth analysis of the wild type 
and FtsHts cells expressing DrrB or DrrAB at 
30 °C or 42 °C was carried out (Figs. 3A and 3B).  
The relative growth of various strains at the four 
hour time point was plotted in a histogram (Fig. 
3C).   The data in Fig. 3A show that the growth of 
mutant FtsHts cells is compromised at 42 °C (Fig. 
3A; 797, open diamonds; Fig. 3C, Column 4) as 
compared to the growth of wild-type cells under 
similar conditions (Figs. 3A, 796, lines; Fig. 3C, 
Column 2).  This result is not surprising due to the 
essential nature of E. coli FtsH.  Interestingly, the 
expression of DrrB alone in FtsHts cells at 42 °C 
further inhibited the growth of these cells (Fig. 3A, 
compare 797, open diamonds with 797/B, filled 
triangles; Fig. 3C, Column 7).  However, growth 
inhibition was not seen when DrrB was expressed 
in wild-type cells at 42 °C (compare 796, lines 
with 796/B, open rectangles; Fig. 3C, column 6).  
Since DrrB accumulates in FtsHts cells but is 
proteolysed in wild-type cells (Fig. 1B), it allows 
us to conclude that the growth defect seen in 
mutant cells is caused by the accumulation of 
unassembled DrrB protein.  Surprisingly, however, 
growth inhibition was also seen in the FtsHts cells 
expressing DrrA and DrrB together at 42 °C (Fig. 
3B, 797/AB, filled triangles; Fig. 3C, Column 7).  
This effect was unexpected because DrrA and 
DrrB can be expressed together in the wild-type 
cells at 42 °C without any negative effect on their 
growth (Fig. 3B, 796/AB, open rectangles; Fig. 3C, 
Column 6).  These data indicate that the DrrAB 
proteins expressed in FtsHts cells at 42 °C may be 
misfolded, and the accumulation of misfolded 
membrane proteins results in growth inhibition.  It 
was also observed that if the FtsHts cells initially 
induced at 42 °C were shifted down to 30 °C, the 
cell growth resumed, albeit slowly.  After 43 hours 
of temperature shift-down, the final growth was 
about half as compared to the cells induced and 
maintained at 30 °C (data not shown), indicating 
that the growth inhibition of these cells is quite 
severe.  In summary, the data in Fig. 3 suggest that 
FtsH is not only responsible for removing 
unassembled DrrB (in the absence of DrrA) but it 
may also be critical for proper assembly of the 
DrrAB complex in the membrane.   
The growth defect of the FtsHts cells 
expressing DrrB or DrrAB at 42 °C could be 
rescued by overexpression of FtsH in trans (Figs. 
3A-B, open triangles; Fig. 3C, Column 8), 
indicating that the absence of functional FtsH was 
solely responsible for this defect.  The growth 
defect in each case was also suppressed by 
overexpression of the chaperone GroESL (Figs. 
3A-B, filled circles; Fig. 3C, Column 9) but not to 
the same extent as seen with FtsH.  Western blot 
analysis of the membrane fractions (prepared from 
the four hour cultures of samples # 6-9 in Figs. 
3A-B) showed that while FtsH overexpression 
resulted in significant proteolysis of DrrAB (Fig. 
3D, lanes 3 and 7), overexpression of GroESL did 
not (lanes 4 and 8).  This might imply that FtsH 
restores growth by simply removing misfolded 
DrrAB proteins, while GroESL is able to alter 
their conformation, thus alleviating growth 
inhibition.    
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FtsH preferentially proteolyzes misfolded 
DrrAB - To determine if FtsH discriminates 
between properly assembled and misfolded DrrAB, 
the effect of overexpression of FtsH proteolysis 
was compared in wild type or FtsHts cells at 30 °C 
or 42 °C.  Interestingly,  overexpression of FtsH in 
either wild type (Figs. 4A-B, compare lanes 1 and 
3) or FtsHts cells (lanes 2 and 4) produced no 
significant proteolysis of DrrA and DrrB 
expressed at 30 °C, showing that FtsH does not 
proteolyze properly assembled DrrAB.  However, 
when the DrrAB proteins were expressed in wild-
type cells at 42 °C, simultaneous overexpression 
of FtsH resulted in significant proteolysis (Figs. 
4A-B, compare lanes 3 and 7).  These data suggest 
that the DrrAB proteins must acquire a partially 
unfolded conformation at a higher temperature (as 
also seen in Fig. 1B), thus making them more 
susceptible to proteolysis by over-expressed FtsH.  
As expected, overexpression of FtsH in FtsHts cells 
also showed significant proteolysis of DrrAB 
expressed at 42 °C (Figs. 4A-B, lanes 4 and 8).  
This is consistent with the data in Fig. 3, which 
suggested that the DrrAB proteins expressed at 
42 °C in FtsHts cells are misfolded.  (Please note 
that the conformation of the DrrAB proteins in 
wild-type cells at 42 °C is completely different 
from the DrrAB expressed in mutant FtsHts cells at 
42 °C even though they are both sensitive to 
overexpressed FtsH.   In a later experiment in Fig. 
8, it is shown that the DrrAB proteins expressed in 
wild type cells at 42 °C retain normal function, 
while the DrrAB expressed in FtsHts cells are 
inactive due to their misfolding)  
The rate of proteolysis of misfolded 
DrrAB by FtsH was analyzed in a separate time-
course experiment.  The misfolded DrrAB proteins 
were first allowed to accumulate in the membranes 
of FtsHts cells by induction with IPTG for 1 hour at 
42 °C.  Chloramphenicol was added to stop further 
synthesis, as described under Methods.  The 
synthesis of FtsH from pBADftsH was induced by 
addition of arabinose, and the proteolysis of DrrA 
and DrrB by FtsH was determined by Western blot 
analysis.  The data in Figs. 4C and 4D (filled 
circles) show that synthesis of FtsH (Fig. 4E, 
lower panel) resulted in increasing proteolysis of 
misfolded DrrA and DrrB from the membrane.  At 
120 minutes after addition of arabinose, about 75-
80% of DrrA and DrrB were removed from the 
membrane.  These observations are in agreement 
with the dislocation model proposed previously for 
the activity of FtsH (8).  No significant proteolysis 
of DrrAB was seen in the absence of FtsH 
synthesis (Figs. 4C and 4D, filled rectangles).    
The AAA domain of FtsH contains a 
chaperone-like activity, but it is not sufficient by 
itself to restore the Dox efflux function - The 
growth experiment in Fig. 3B suggested that FtsH 
may be critical for the assembly of the DrrAB 
complex.  Further support for this idea was 
obtained by comparing the rate of assembly of the 
DrrAB complex in wild type and FtsHts cells.  The 
data in Fig. 5 show that the assembly of DrrA and 
DrrB in the membrane of FtsHts cells is 
significantly compromised already at 30 °C as 
compared to in the wild type cells.  A significant 
difference in the amounts of DrrAB in the 
membrane of wild type and mutant cells was seen 
at all time points tested (Fig. 5, compare lanes 1-3 
with 7-9).  However, this difference is most 
evident at the early time points, which suggests 
that the rate of assembly of DrrAB is affected by 
FtsH.  This is most likely due to the partial defect 
of FtsH function in FtsHts cells already at 30 °C, 
leading to the low efficiency of the DrrAB 
complex formation.   
To determine if the ability to promote 
assembly of DrrAB resides in the AAA domain of 
FtsH, variants containing mutations in the Walker 
A motif of the AAA domain (K198N mutation) or 
the conserved amino acids in the proteolytic 
domain (the HEH mutation and the AAA subclone 
are described under Methods) were created.  The 
K198N allele contained a defective AAA domain, 
while the HEH mutant and the AAA subclone 
contained an intact AAA domain.  As expected, 
the K198N mutation resulted in a significantly 
reduced ATPase activity, however the HEH 
mutant and the AAA subclone were unaffected 
(Table 2).  The in vitro proteolytic activity assay 
showed that while the wild-type FtsH completely 
proteolyzed α-casein in one hour, no significant 
reduction in the α-casein level was seen with the 
HEH mutant even after two hours of incubation 
(Fig. 6).  These analyses confirmed that the AAA 
and the proteolytic domain mutants behave as 
expected.  Therefore, they were used in two 
different complementation experiments (described 
below) to determine if the AAA domain by itself 
is sufficient for promoting assembly of the DrrAB 
complex.   
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The expression of the DrrAB proteins in 
FtsHts cells was previously shown to result in 
severe growth inhibition (Fig. 3B, filled triangles).  
This inhibition was reversed by simultaneous 
expression of FtsH (Fig. 3B, open triangles).  In 
the next experiment, we asked whether co-
expression of the HEH allele or the AAA subclone 
can rescue FtsHts cells from the growth inhibition 
resulting from DrrAB expression.  The data in Fig. 
7 show that the simultaneous expression of either 
the HEH mutant (Fig. 7A, open circles) or the 
AAA subclone (Fig. 7A, filled triangles) with 
DrrAB can complement the growth defect of 
FtsHts cells, indicating that the AAA domain of 
FtsH indeed contains a chaperone-like activity.  
Interestingly, the HEH mutant showed much better 
complementation of the growth defect as 
compared to the AAA subclone, perhaps due to a 
more native conformation of the full-length HEH 
protein as compared to the AAA subclone.  The 
K198N mutation, on the other hand, showed no 
growth complementation effect (Fig. 7A, open 
triangles), showing that the ATPase activity 
associated with the AAA domain is important for 
the chaperone function of FtsH.  Western blot 
analysis showed that the DrrAB complex is 
membrane-associated in the FtsH(HEH), 
FtsH(AAA), and FtsH (K198N)-containing strains 
(Figs. 7B and 7C, lanes 5-7), and the amounts of 
DrrA and DrrB in these cells were comparable to 
the levels in their absence (lane 3).  Therefore the 
restoration of growth by the HEH and AAA clones 
must result from a change in conformation of the 
DrrAB proteins brought about by the functional 
AAA domain present in these two clones.  
Whether the HEH and AAA variants of FtsH can 
also restore function of the DrrAB complex is 
addressed in the next experiment. 
We previously showed that the wild-type 
DrrA and DrrB proteins together carry out ATP-
dependent efflux of the anticancer drug 
doxorubicin (3).  Here, we investigated whether 
co-expression of the AAA subclone or the HEH 
allele can restore the Dox efflux function of the 
misassembled DrrAB proteins expressed in FtsHts 
cells at 42 °C (Fig. 8).  The data in Fig 8A indicate 
that the rate of DrrAB-mediated Dox efflux at 
30 °C in the wild-type 796 and FtsHts 797 cells is 
comparable (Columns 1 and 3).   Induction of 
wild-type cells at 42 °C showed only a slight 
reduction in Dox efflux (Column 2), which is 
likely due to the destabilization effect produced by 
high temperature on DrrAB, as seen earlier in Figs. 
1 and 4.  By contrast, the FtsHts cells induced at 
42 °C showed very little or no DrrAB-mediated 
Dox efflux (Fig. 8A, column 4), which was 
comparable to the efflux seen with control cells 
containing empty vector (Fig. 8A, Columns 5 and 
6).  These data confirm that the DrrAB proteins 
are misfolded in the absence of functional FtsH.  
Simultaneous overexpression of the FtsH variants, 
K198N, HEH or the AAA subclone, in FtsHts cells 
did not restore function of misassembled DrrAB 
(Fig. 8B, columns 4-6), even though restoration of 
growth by HEH and the AAA subclone was earlier 
seen in Fig. 7A.  Similarly, overexpression of 
GroESL also did not complement the DrrAB-
mediated Dox efflux in FtsHts cells (Fig. 8B, 
column 7).  One possible explanation for these 
data could be that even though the AAA domain 
of FtsH (or GroESL) is able to alter the 
conformation of the DrrAB proteins and relieve 
growth inhibition, it is not sufficient by itself to 
restore proper conformation required for full 
function of the complex.   
Wild-type FtsH can refold previously 
misassembled DrrAB and restore function - 
Surprisingly, co-expression of wild-type FtsH 
restored the Dox efflux function of the 
misassembled proteins expressed in FtsHts cells at 
42 °C resulting in a significant recovery (about 
45%) of Dox efflux by the DrrAB complex (Fig. 
8B; compare columns 2 and 3).  Since this could 
only have resulted if FtsH expressed in trans 
facilitated assembly of the complex, these results 
imply that the AAA and the proteolytic domains of 
FtsH must work hand-in-hand to bring about 
functional assembly of the DrrAB complex.  In 
this experiment, however, FtsH and the DrrAB 
proteins were expressed simultaneously by IPTG 
induction, therefore it was not possible to 
determine if FtsH assists only the newly 
synthesized DrrAB to achieve proper 
conformation, or if it can also bring about 
refolding of the DrrAB proteins that have already 
been misfolded.  
Therefore, in the next experiment, DrrAB 
and wild-type FtsH were expressed in FtsHts cells 
in a sequential manner.  The ftsH gene subcloned 
under the control of the araBAD promoter was 
induced by arabinose, while the drrAB genes 
remained under the control of the lac promoter 
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induced by IPTG.  The FtsHts cells containing both 
the plasmids (797/AB/pBADftsH) were grown at 
30 °C to mid-log phase.  The DrrAB proteins were 
first induced with IPTG at 42 °C for 1 hour (this 
condition inactivates FtsH and renders DrrAB 
inactive as seen in Figs. 8A and 8B).  The cells 
were then washed several times to remove 
extracellular IPTG and stop further synthesis of 
DrrAB.  The expression of FtsH was induced by 
arabinose for 1 hour at 42 °C, and the cells were 
subjected to the Dox efflux assay.  To maintain the 
chromosomally-encoded FtsH in an inactive 
conformation, the temperature was maintained at 
42 °C throughout the duration of the experiment.  
As previously seen in Fig. 8B, simultaneous 
expression of DrrAB and FtsH resulted in 
restoration of Dox efflux (Fig. 8C; 
797/AB/pUCftsH, column 3).  More interestingly, 
however, even greater restoration of the DrrAB-
mediated Dox efflux was seen when FtsH was 
induced after DrrAB proteins had been pre-
synthesized in these cells (Fig. 8C, 
797/AB/pBADftsH+ara, column 5).  In the 
absence of arabinose induction of FtsH, much 
lower restoration of Dox efflux was seen (Fig. 8C, 
797/AB/pBADftsH – ara, column 4).  These data, 
therefore, show that the sequential expression of 
DrrAB and FtsH can still restore the function of 
the previously misfolded DrrAB proteins to the 
same (or even higher) extent as seen with 
simultaneous expression.  
Finally, the effect of over-expression of 
FtsH on Dox efflux function of DrrAB expressed 
at different temperatures was investigated.  
Irrespective of whether the DrrAB proteins were 
induced at 30 °C, 37 °C, or 42 °C in FtsHts cells, 
simultaneous expression of FtsH resulted in a very 
similar final Dox efflux efficiency (Fig. 8D).  At 
42 °C, co- expression of FtsH enhanced Dox 
efflux of misfolded DrrAB 5-fold (compare 
columns 3 and 6), yielding about 45% Dox efflux 
efficiency.  Interestingly, over-expression of FtsH 
at 30 °C or 37 °C reduced the efficiency by about 
half (compare columns 1-2 with 4-5), once again 
yielding final Dox efflux efficiency of about 45%.  
These results imply that FtsH produces an optimal 
level of functional complexes in the membrane 
perhaps by exerting both proteolytic and refolding 
effects concurrently.   
 
 
DISCUSSION 
Non-native proteins, especially unassembled 
membrane proteins, interfere with cellular 
processes and are known to become toxic to the 
cells.  Therefore, quality control systems, 
consisting of chaperones and proteases, play 
essential roles by monitoring their folding and 
either refolding or degrading misfolded proteins 
(21-23).  Hsp60 (GroEL/ES) and Hsp70 (DnaK) 
proteins provide classical examples of ATP-
dependent chaperones which prevent aggregation 
of newly translated proteins and promote their 
refolding (22).  A special class of chaperones (e.g. 
ClpB in bacteria and its homologs Hsp78 and 
Hsp104 in eukaryotes) is known to resolubilize 
protein aggregates and, in cooperation with the 
Hsp70 chaperones (specifically DnaKJE), can 
result in regaining function of the affected protein 
(15).  On the other end of the spectrum are 
proteins classically defined as proteases, for 
example Lon, ClpA/P, ClpX/P and FtsH, whose 
major function is considered to be removal of 
irreversibly damaged proteins from the cell 
(6,14,24).  Despite their differences, however, 
both classical chaperones and proteases share 
common features.  For example, both have the 
ability to recognize and bind non-native 
polypeptides and both bring about unfolding of 
their substrates, which are subsequently refolded 
(by a chaperone) or degraded (by a 
protease)(12,22,25).  Because of the ATP-
dependent unfolding function of AAA+ proteases, 
it has been speculated that they may also have the 
ability to refold substrate proteins and may 
participate in protein biogenesis.  However, very 
little direct evidence is available for the role of 
FtsH or other AAA+ proteases in biogenesis, 
especially of membrane protein complexes.   In 
this study, we provide clear evidence that the E. 
coli FtsH is able to both degrade and refold 
misassembled DrrAB proteins, resulting in 
regaining the Dox efflux function of the 
membrane complex.   
We show that in the absence of the DrrA 
protein, DrrB acquires an FtsH-sensitive 
conformation and is completely proteolyzed.  
However, in the absence of functional FtsH, the 
DrrB protein accumulates even in the absence of 
DrrA confirming that FtsH monitors the folding 
status of DrrB and removes it if it is improperly 
assembled.  The molecular details of proteolysis of 
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DrrB by FtsH are currently unknown, however 
based on the prevalent model for its action (8,26) 
we assume that FtsH could initiate proteolysis of 
DrrB either at the N- or the C-terminal end (both 
of which are found in the cytoplasm, (27)).  Cross-
linking studies previously showed that the N 
terminus of DrrB is the major site of interaction 
with DrrA (3,27); therefore we propose that 
proteolysis of DrrB initiates at its N- terminal tail, 
and binding of DrrA to this region of DrrB 
protects it from proteolysis by FtsH. 
Interestingly, we found that the function 
of FtsH is not limited to proteolysis of 
unassembled DrrB, but it also plays an essential 
role in folding and assembly of the DrrAB 
complex.  This conclusion is supported by several 
lines of evidence presented in this paper.  First, the 
expression of DrrA and DrrB together in FtsHts 
cells at 42 °C (which results in inactivation of 
FtsH) was found to be growth inhibitory (Fig. 3B) 
suggesting that the complex is improperly 
assembled in the absence of a functional FtsH.  
Second, the rate of assembly of the DrrAB 
complex in the FtsHts cells at 30 °C was found to 
be significantly reduced as compared to the wild-
type cells (Fig. 5).  Third, functional analysis 
showed complete absence of the DrrAB-mediated 
Dox efflux in FtsHts cells under conditions of FtsH 
inactivation, suggesting that most or all of the 
DrrAB proteins expressed in these cells at 42 °C 
are misassembled.  By contrast, the DrrAB 
proteins expressed in wild-type cells at 42 °C 
retained on average 85-90% of the Dox efflux 
activity (Fig. 8A).  Finally, co-expression of FtsH 
in trans in FtsHts cells restored the ability of 
DrrAB to carry out Dox efflux, confirming that 
FtsH facilitates assembly of the DrrAB complex 
(Fig. 8B).  Nevertheless, this result was surprising 
because FtsH contains a functional proteolytic 
domain.  It’s overexpression in FtsHts cells results 
in proteolysis of the misfolded DrrAB proteins (as 
seen in Fig. 4), however the data in Fig. 8B show 
that FtsH also facilitated some folding resulting in 
about  45% recovery of the Dox efflux activity.  
Either the AAA domain by itself or the GroESL 
chaperone was unable to complement the Dox 
efflux function of DrrAB in FtsHts cells, even 
though each was able to alleviate the growth 
defect.  Therefore, together these data suggest that 
both the AAA and the protease domains of FtsH 
are essential for promoting functional assembly of 
DrrAB.  
The most crucial evidence for the 
refolding function of FtsH, however, came from 
the sequential expression studies.  Irrespective of 
whether FtsH was expressed simultaneously with 
DrrAB or expressed after the non-functional DrrA 
and DrrB proteins had already accumulated in 
FtsHts cells, it was able to restore the function of 
the complex (Fig. 8C), thus showing conclusively 
that FtsH not only facilitates assembly of the 
DrrAB complex but it is also actively involved in 
refolding previously misassembled DrrAB 
proteins.  Interestingly, we also found that the 
sequential expression of DrrAB and FtsH resulted 
in a significantly higher recovery of the Dox efflux 
function of DrrAB as compared to simultaneous 
expression (Fig. 8C).  This finding suggests that 
FtsH treats its substrate differently during its 
synthesis as compared to after it has already been 
synthesized.   
In summary, our studies confirm that the 
AAA domain of FtsH can recognize and bind 
substrates and change their conformation, which is 
in agreement with the previous studies (18).  
However, we also show that the two activities 
(ATPase and proteolytic) of FtsH must be present 
simultaneously and occur in a coordinated manner 
to facilitate assembly and refolding of DrrAB.  
Much more extensive analysis will be required in 
the future to understand the nature of the 
molecular processes involved in refolding of DrrA 
and DrrB and to determine if other factors also 
play a role in the assembly of the DrrAB complex.  
Further studies will also provide clues about how 
degradation and assembly of multi-subunit 
complexes are regulated, and whether other AAA+ 
proteases may also contain chaperone activity.  
This study raises intriguing questions about the 
distinction between classical chaperones like 
GroESL (that can prevent aggregation of many 
proteins) and the classical proteases like FtsH that 
not only carry out proteolysis but also actively 
participate in refolding of their specific substrates, 
as shown in this study.  Bukau and Mogk 
previously (22) coined four terms to describe the 
various activities of chaperones and proteases: 
Holders (small heat shock proteins, Hsps), Folders 
(GroESL and DnaK), Unfolders (ClpA, ClpX, and 
ClpB), and Proteases (Lon, ClpP, and FtsH).  In 
light of the findings reported in this article, we 
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propose a new term ‘Specific Refolder’ to describe 
the function of FtsH and possibly other AAA+ 
proteases that may be shown in the future to 
contain such an activity.     
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FIGURE LEGENDS 
FIGURE 1. Role of DrrA and FtsH in stable maintenance of DrrB. (A) DrrA is required for stable 
expression of DrrB.  Wild-type E.coli (TG1) cells expressing DrrAB (pDX101) or DrrB alone (pDX103) 
were grown at 37° C to mid-log phase (A600nm=0.6) and induced with 0.25 mM IPTG for 3 h.  30 µg 
membrane proteins were loaded onto 12% SDS-PAGE gels, followed by Western blotting against anti-
DrrA (upper panel) and anti-DrrB (lower panel) antibodies.  (B) FtsH is responsible for proteolysis of 
unassembled DrrB.  Wild-type E. coli (796) or the E. coli 797 (ftsHts) cells expressing DrrAB (pDX101) 
or DrrB alone (pDX103) were grown at 30 °C to mid-log phase and induced with 0.25 mM IPTG at either 
30 °C or 42 °C for 3 h.  Western blot analysis of the membrane fraction was carried out as in Fig. 1A.  (C) 
ClpA/P or the Lon protease is not involved in quality control of DrrB. Wild-type E. coli (796), E. coli 
797 (ftsHts), E. coli SG1110 (Lon-), and E. coli SG1126 (ClpA-) cells expressing DrrAB (pDX101) or 
DrrB alone (pDX103) were grown at 30 °C or 37 °C to mid-log phase and induced with 0.25 mM IPTG at 
either 42 °C or 37 °C for 3 h, as indicated.  Analysis was carried as described in (B) above.   
 
FIGURE 2. Western blot analysis of the cytosol, membrane, and inclusion body fractions of E. coli 
796 or 797 cells expressing DrrAB at 30 °C or 42 °C.  Wild-type E. coli 796 or the E. coli 797 (ftsHts) 
cells expressing DrrAB (pDX101) were grown at 30 °C to mid-log phase and induced with 0.25 mM 
IPTG at either 30 °C or 42 °C for 3 h.  Cell fractions were prepared, as described under Methods.  20 µg 
of each fraction was loaded onto 12% SDS-PAGE gels, followed by Western blotting against anti-DrrA 
(upper panel) and anti-DrrB (lower panel) antibodies.  (m, membrane; c, cytosol; IB, inclusion body).  
Note that the anti-DrrB antibody is an anti-peptide antibody, therefore it shows some cross-reactivity with 
epitopes in other E. coli proteins, as explained in a previous publication (1). 
 
FIGURE 3. Growth inhibition resulting from expression of DrrB alone or DrrAB together in E. coli 
797 cells can be relieved by the overexpression of FtsH or GroESL. (A) Effect of overexpression of 
FtsH or GroESL on growth of 797 cells expressing DrrB.  797 cells containing pDX103 (DrrB) and 
pUCftsH or pUCgroESL were grown at 30 °C and induced at 42 °C, as in Fig. 1B.  The growth was 
monitored at O.D. 600 nm for four hours after induction.  (B) Effect of overexpression of FtsH or 
GroESL on growth of 797 cells expressing DrrAB.  797 cells containing pDX101 (DrrAB) and 
pUCftsH or pUCgroESL were anayzed, as described in (A) above.  (C) Quantitation of the growth of 
796 or 797 cells expressing DrrB or DrrAB at 4 hours after induction. The growth of the sample #1 at 
4 hours in Fig. 3A or 3B was designated as 1.0.  The relative growth of each culture at 4 hours was 
calculated.  The histogram represents an average of 3 experiments.  Columns 1-9 correspond to the 
cultures 1-9 in Figs 3A (filled) and 3B (open).  (D) Western blot analysis.  The membrane fractions were 
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prepared from sample #s 6-9 collected at the 4 hour time point in Fig. 3A and 3B.  Western blot analysis 
was carried out as in Fig. 1(A).   
 
FIGURE 4.  FtsH preferentially degrades misfolded DrrAB.  (A) E. coli 796 or 797 cells containing 
pDX101(DrrAB) and  pUCftsH were grown and analyzed by Western blotting, as in Fig. 1A.  (B) 
Quantitative analysis of the amounts of DrrA and DrrB.  The intensity of the bands on the 
nitrocellulose membrane in Fig. 4A was determined by densitometric scanning.  The intensity of DrrA 
and DrrB in lane 1 was designated as 1.  The data represent an average of 3 experiments.  Columns 1-8 
correspond to the lanes 1-8 in Fig. 4A.  (C), (D) and (E) In vivo FtsH proteolytic assay.  The assay was 
carried out as described under Methods.  The membrane fractions were prepared from the cells collected 
at the indicated time points after addition of arabinose.  20 µg total membrane protein was loaded onto 12% 
SDS-PAGE, followed by Western blot with anti-DrrA, anti-DrrB, or anti-FtsH antibodies.  The intensity 
of the bands on the nitrocellulose membrane was determined by densitometric scanning.  The intensity of 
DrrA and DrrB on the membrane at 0 min was designated as 1.0.  (C) Quantitation of DrrA in the 
membrane at the indicated time points after addition of arabinose.  The data shown represent an average 
of 3 experiments.  (D) Quantitation of DrrB in the membrane.  (E) Western blot analysis showing amount 
of FtsH present in the membrane at various times after addition of arabinose.  Top panel:  cells containing 
pBAD vector only.  Bottom panel: cells containing the plasmid pBADftsH.   
 
FIGURE 5. FtsH promotes assembly of the DrrAB complex.  (A) E. coli 796 or 797 cells expressing 
DrrAB were grown at 30 °C to mid-log phase and the culture was divided into two halves.  One half was 
induced  with 0.25 mM IPTG at 30° C (lanes 1-3 for 796 and  lanes 7-9 for 797) and  the other half was 
induced at 42 °C (lanes 4-6 for 796 and lanes 10-12 for 797).  Aliquots of each sample were collected at 
30 min intervals. Hours of induction are shown at the top of the gel. 0 hour represents A600nm = 0.6 at 
which time IPTG was added.  Western blot analysis was carried out as in Fig. 1A.  (B) The quantitative 
analysis of DrrA and DrrB.  The intensity of bands on the nitrocellulose membrane was determined by 
densitometric scanning.  The intensity of DrrA and DrrB in lane 1 was designated as 1.  The data 
represent an average of 3 experiments. 
 
FIGURE 6. In vitro digestion of α-casein by purified FtsH or FtsH(HEH).  (A) α-casein was mixed 
with purified wild-type FtsH or FtsH (HEH) protein in the protease buffer as described in the Methods.  
The samples were analyzed by 12% SDS-PAGE, followed by Coomassie Brilliant blue staining.  (B) 
Quantitative analysis of the amounts of α-casein.  The intensity of the bands on the nitrocellulose 
membrane was determined by densitometric scanning.  The intensity of α-casein in lane 1 was designated 
as 1.  The intensities represent an average of 3 experiments.  
 
 FIGURE 7. The AAA domain of FtsH is sufficient to complement the growth defect resulting from 
the expression of DrrAB in 797 cells.  E. coli 797 cells containing the drrAB genes (pDX101) and the 
wild-type or a mutated version (K198N, HEH, or AAA subclone) of the ftsH gene on a compatible 
plasmid were grown at 30 °C and induced at 42 °C, as in Fig. 1B.  (A) Growth analysis at 600 nm. (B) 
Western blot analysis.  Membranes prepared from the cells collected at the 3 hour time point were 
analyzed, as in Fig. 1A.  (C) Quantitative analysis of DrrA and DrrB.  The intensity of the bands on 
the nitrocellulose membrane in Fig. 7B was determined by densitometric scanning.  The intensity of DrrA 
and DrrB in lane 1 was designated as 1.0.  The data shown represent an average of 3 experiments.  The 
columns 1-8 correspond to samples 1-8 in Fig. 7B.  
 
FIGURE 8.  DrrAB-mediated Dox efflux.  (A) Dox efflux in E. coli 796 or 797 cells.  The cells 
containing pDX101 (DrrAB) or the empty vector were grown at 30 °C to mid-log phase and induced with 
0.1 mM IPTG at either 30 °C or 42 °C for 1 h.  The washed cells were loaded with Dox, and efflux was 
initiated by addition of glucose and detected fluorometrically.  The slope of the efflux curve of sample 1 
in each panel was designated as 1.0.  The efficiency of Dox efflux was then calculated by dividing the 
14 
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slope of each efflux curve by the slope of sample 1.  The average data obtained from three independent 
experiments are shown in the histograms.  (B) Complementation of the DrrAB-mediated Dox efflux in 
797 cells by simultaneous overexpression of wild-type FtsH or its variants.  E. coli 797 cells 
containing pDX101(DrrAB) and  pUCftsH (wild-type FtsH), pUCftsH(K198N), pUCftsH(HEH), 
pUCftsH(AAA) or pUCgroESL, were analyzed as described under (A) above.  (C)  Effect of sequential 
expression of DrrAB and FtsH on complementation of Dox efflux.  E. coli 797 cells containing 
pDX101 (DrrAB) and pBADftsH were grown at 30 °C to mid-log phase and induced with 0.1mM IPTG 
for 1 h at 42 °C.  The cells were washed extensively to remove IPTG and divided into two halves.  One 
half was kept at 42 °C for 1 h without any induction (-ara, 42 °C) and the other half was induced by 1% 
arabinose at 42 °C (+ara, 42 °C) for 1 h.  As controls, 796/AB, 797/AB and 797/AB/pUCftsH were grown 
at 30 °C to mid-log phase and induced with 0.1 mM IPTG at 42 °C for 2 h.  The cells were loaded with 
Dox, and efflux was measured.   The data were analyzed as described under (A) above.  (D)  Effect of 
simultaneous over-expression of FtsH on Dox efflux by DrrAB proteins expressed at different 
temperatures. 797 cells containing pDX101 (DrrAB) and pUCftsH were grown at 30 °C to O.D. 0.6, 
induced with 0.1 mM IPTG at 30 °C, 37 °C or 42 °C for 1 h, and analyzed as in (A) above. 
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TABLE 1. Bacterial strains, plasmids, and antisera 
 
Name Description Reference 
or Source 
Bacterial Strains 
TG1 K-12 Δ(lac-pro) supE thi hsdD5/F’ tra36 proA+B+ lacIq lacZΔM15 (28) 
HMS174(DE3) F- recA1 hsdR (rK12- mK12+) (DE3) (Rif R) (28) 
AR796 F-, zhd-33::Tn10, araD139, (argF-lac)U169, rpsL150, rpsE, relA1, 
f1bB5301, deoC1, ptsF25, rbsR, zgj3198::Tn10kan. 
(29) 
AR797 F-, zhd-33::Tn10, araD139, (argF-lac)U169, rpsL150, rpsE, relA1, 
f1bB5301, deoC1, ptsF25, rbsR, zgj3198::Tn10kan. ftsH1 
(29) 
SG1110 Δlon-510, zba-1091:: ΔTn10(λ) (30) 
SG1126 Δarg, clpA319:: Δkan (30) 
Plasmids 
pSU2718 Cloning vector, pACYC184 derivative, Cmr (1) 
pKY326 groES/groEL in pHSG575, Cmr (19) 
pDX101 drrAB in pSU2718, Cmr (1) 
pDX103 drrB in pSU2718, Cmr (1) 
pUCftsH ftsH  in pUC18, Ampr, restriction sites: EcoRI, HindIII This study 
pUCftsH(K198N) pUC18 containing ftsH with mutation of Lys198 to Asn, Ampr This study 
pUCftsH(HEH) pUC18 containing ftsH with  mutations of His417Glu418His421  to 
Ala417Gln418Ala421, Ampr 
This study 
pUCftsH(AAA) pUC18 containing ftsH with deletion of proteolytic domain, Ampr This study 
pUCgroESL groES/groEL in pUC18, Ampr, restriction sites: NdeI, HindIII This study 
pETftsH ftsH in pET28a with C-terminal histag, Kanr This study 
pETFftsH(K198N) ftsH(K198N) in pET28a with C-terminal histag, Kanr This study 
pETftsH(HEH) ftsH(HEH) in pET28a with C-terminal histag, Kanr This study 
pETftsH(AAA) ftsH(AAA) in pET28a with C-terminal histag, Kanr This study 
pBADftsH ftsH in pBAD/HisA, Ampr This study 
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TABLE2.  The ATPase activity of purified FtsH and its variants 
The proteins were purified, and their ATPase activity was determined as described in Methods. 
FtsH Variant ATPase Activity (nmol Pi/min/mg) 
Wild-type FtsH                          139.5 
FtsH(K198N)                            18.1 
FtsH(HEH)                          147.8 
FtsH(AAA)                          155.6 
 
 
  
17 
 
 at G
EO
RG
IA
 STA
TE U
N
IV
 on Septem
ber 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Figure 1 
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Figure 2 
  
19 
 
 at G
EO
RG
IA
 STA
TE U
N
IV
 on Septem
ber 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Figure 3 
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Figure 4 
 
 
 
  
21 
 
 at G
EO
RG
IA
 STA
TE U
N
IV
 on Septem
ber 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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